BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 57.35
-0.87 (-1.49%)
At close: Apr 17, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 24.23 billion as of April 17, 2026. Its market cap has increased by 42.10% in one year.
Market Cap
24.23B
Enterprise Value
25.99B
Revenue
1.22B
Ranking
n/a
PE Ratio
444.52
Stock Price
57.35
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 24.23B, an increase of 93.09%. That is a compound annual growth rate of 10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 24.23B | 16.84% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai RAAS Blood Products | 37.37B |
| Chongqing Zhifei Biological Products | 37.03B |
| Beijing Tiantan Biological Products | 30.02B |
| Hualan Biological Engineering | 27.48B |
| Xiamen Amoytop Biotech | 26.37B |
| Suzhou Zelgen Biopharmaceuticals | 26.15B |
| Yili Chuanning Biotechnology | 23.01B |
| Sinocelltech Group | 20.81B |